AI Science Tracker
EN

HSF1 modulates lipid metabolism and ferroptosis in sarcopenia: a novel diagnostic biomarker and therapeutic target

Department of Clinical Medicine, Fujian Medical University Union Hospital, China; Department of Orthopedics, Fujian Medical University Union Hospital, China; Department of Respiratory and Critical Care Medicine, Fujian Medical University Union Hospital, China · 30 Apr 2026 · biology

Discovery

HSF1 modulates lipid metabolism and ferroptosis in sarcopenia: a novel diagnostic biomarker and therapeutic target

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Methods and Results: RNA-seq GSE25941/GSE9103; WGCNA and LASSO/SVM/KNN/XGBoost/NNET shortlist six FRGs; HSF1 highest diagnostic AUC (0.9247); C2C12 silencing/overexpression assays measure lipid metabolism, ferroptosis and atrophy markers.

Technology: Methods and Results: RNA-seq GSE25941/GSE9103; WGCNA and LASSO/SVM/KNN/XGBoost/NNET shortlist six FRGs; HSF1 highest diagnostic AUC (0.9247); C2C12 silencing/overexpression assays measure lipid metabolism, ferroptosis and atrophy markers.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Methods and Results: RNA-seq GSE25941/GSE9103; WGCNA and LASSO/SVM/KNN/XGBoost/NNET shortlist six FRGs; HSF1 highest diagnostic AUC (0.9247); C2C12 silencing/overexpression assays measure lipid metabolism, ferroptosis and atrophy markers.
Limitation / still unknown
nockdown/overexpression assays measured associated lipid-metabolism, ferroptosis and atrophy effects.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2026.1727633/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.